Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 8—August 2002

Research

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan

Po-Ren Hsueh*, Lee-Jene Teng*, Cheng-Yi Chen*, Wen-Hwei Chen*, Shen-Wu Ho*Comments to Author , and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article

Table 1

In vitro susceptibilities for 203 clinical isolates of pandrug-resistant Acinetobacter baumannii (PDRAB) determined by disk diffusion

MIC (µg/mL) % of isolates
Antibiotic
Range
MIC50
MIC90
S
I
R
Ampicillin 64–>128 >128 >128 - - -
SAM 4–>128 64 128 3 3 94
Ceftazidime 16–>128 >128 >128 0 1 99
Cefepime 16–>128 >128 >128 0 1 99
Flomoxef 64–>128 >128 >128 - - -
TZP 32–>128 >128 >128 0 4 96
Aztreonam 8–>128 64 128 1 1 98
Imipenem 8–64 8 32 0 62 38
Meropenem 8–128 16 128 0 8 92
Amikacin 32–>128 >128 >128 0 6 94
Ciprofloxacin 2–>128 64 128 0 6 94
Trovafloxacin 4–32 8 16 - - -
Moxifloxacin 2–16 8 16 - - -

TZP, piperacillin-tazobactam; SAM, ampicillin-sulbactam.

Main Article

TOP